- Home
- PASG vs MNDO Comparison
PASG vs MNDO Comparison
Compare PASG & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PASG | MNDO |
|---|---|---|
| Founded | 2017 | 1995 |
| Country | United States | Israel |
| Employees | 27 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.3M | 24.2M |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PASG | MNDO |
|---|---|---|
| Price | $9.35 | $1.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $34.50 | N/A |
| AVG Volume (30 Days) | 31.2K | ★ 35.6K |
| Earning Date | 04-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 18.80% |
| EPS Growth | ★ 42.47 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.28 | $0.98 |
| 52 Week High | $20.00 | $2.08 |
Technical Indicators
Market Signals| Indicator | PASG | MNDO |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 45.87 |
| Support Level | $6.31 | $1.12 |
| Resistance Level | $10.71 | $1.24 |
| Average True Range (ATR) | 0.99 | 0.05 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 34.33 | 40.00 |
Price Performance
Historical ComparisonAbout PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.